跳至主導覽
跳至搜尋
跳過主要內容
澳門理工大學 首頁
English
中文
在 澳門理工大學 搜尋內容
首頁
研究單位
研究成果
學術履歷
新聞/媒體
連絡專家
查看斯高帕斯 (Scopus) 概要
DUAN HONGLIANG
Associate Professor
Associate Professor
,
Faculty of Applied Sciences
電話
8599 6829
電子郵件
hduan
mpu.edu
mo
h-index
772
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2009
2026
每年研究成果
概覽
指紋
網路
研究成果
(66)
新聞/媒體
(13)
類似的個人檔案
(1)
指紋
查看啟用 HONGLIANG DUAN 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Cyclic Peptide
100%
Amino Acids
31%
Artificial Intelligence
31%
Structure Prediction
26%
Endoplasmic Reticulum Stress
24%
Interleukin
22%
Cytokine
22%
Protein Expression
22%
Transfer of Learning
22%
Protein Structure
19%
Small Molecule
16%
in Vitro Selection
14%
Binding Affinity
14%
Cell Death
14%
Allele
12%
Cancer Cell
11%
Disulfide
11%
Human Leukocyte Antigen
11%
Binding Site
11%
EC50
11%
Agonist
11%
Antidiabetic Activity
11%
5-Methylcytosine
11%
Computer Assisted Diagnosis
11%
Fetus Development
11%
Protein Structure Prediction
11%
Conjugate
11%
Contrastive Learning
11%
Peptide Nucleic Acid
11%
Stability Prediction
11%
Methylation
11%
Enzyme Classification
11%
Protein Property
11%
Protein Complexes
11%
Glucose Blood Level
8%
Transdifferentiation
7%
Mediator
6%
Peptide Sequence
6%
Unfolded Protein Response
6%
Cell Survival
5%
Peptide Library
5%
Structure Activity Relation
5%
Peptide Stability
5%
Biological Phenomena and Functions Concerning the Entire Organism
5%
Drug Development
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclopeptide
55%
EC50
33%
Amino Acid
33%
Non Insulin Dependent Diabetes Mellitus
27%
Carboxamide
22%
Triple Negative Breast Cancer
22%
Antidiabetic Agent
16%
Drug Development
15%
Side Effect
14%
Drug Discovery
12%
Structure Activity Relationship
12%
High-Throughput Screening
11%
Protective Agent
11%
Interleukin 17C
11%
Quinazoline Derivative
11%
Fatty Acid
11%
Tunicamycin
11%
Palmitic Acid
11%
Nitrofuran
11%
Adenosine Triphosphate
11%
Disulfide
11%
Leukocyte Antigen
11%
Drug Interaction
11%
Aurovertin
11%
Triazole
11%
Ferroptosis
11%
Antibody Drug Conjugate
11%
Myricetin
11%
Peptide Nucleic Acid
11%
Stability Prediction
11%
Dextro Amino Acid
11%
Glucagon-Like Peptide-1
9%
IC50
7%
Adverse Event
7%
Oxyntomodulin
5%
Interleukin 17
5%
Isoenzyme
5%
Functional Groups
5%
Receptor
5%
Malignant Neoplasm
5%
Peptide Stability
5%
Chemistry
Bioactivity
22%
Hydrogenation
22%
Peptide Library
16%
IC50
12%
Diels-Alder Reaction
11%
Ruthenium
11%
Michael Addition
11%
Addition Reaction
11%
EC50
11%
Phosphodiesterase V Inhibitor
11%
Reaction Intermediate
11%
Cyclic Peptide
11%
Boronic Acid
11%
Secondary Alcohol
11%
Named Reaction
11%
Chan-Lam Coupling
11%
Heck Reaction
11%
Dehalogenation
11%
Transition Metal
11%
Coupling Reaction
11%
Myricetin
11%
Continuous Flow Reaction
11%
Biofilm Formation
11%
Peptide Nucleic Acid
11%
Flow Reaction
11%
Organic Chemistry
8%
Organic Reaction
8%
Suzuki Reaction
5%
Regioselectivity
5%
Stereochemistry
5%
Pharmaceutical Industry
5%
Radical Addition
5%
Phosphoryl
5%
Hydroxyl Group
5%
Triflyl Group
5%
Bismuth
5%
Arylation
5%
Natural Product
5%
Kd
5%
Base
5%
